Ambu's stock hits lowest price in five years

An analyst from Carnegie says there are several factors explaining why the medtech firm’s share price has declined to a level not seen since 2017.
Photo: PR / Ambu
Photo: PR / Ambu
by marketwire, translated by daniel pedersen

Ambu has been facing headwinds on the stock exchange in recent days, and Head of Equity Research at Carnegie Investment Bank Niels Granholm-Leth has identified several potential factors as to why.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading